1Neil DA,Hubscher SG.Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection[J]? Transplantation,2001,71:1566-1572.
2Sugawara Y,Makuuchi M.Liver transplantation forhepatitis B virus cirrhosis[J].Nippon Rinsho(Review),2004,62 (Suppl8):363-366.
3Anonymous.Banff schema for grading liver allograft rejection:an international consensus document[J].Hepatology (Review),1997,25:658-663.
4Neuhaus P,Clavien PA,Kittur D,et al.Improved treatment response with basiliximab immunoprophylaxis after liver transplantation:results from a double-blind randomized placebocontrolled trial[J].Liver Transpl,2002,8:132-142.
5Tsamandas AC,Jain AB,Felekouras ES,et al.Central venulitis in the allograft liver:a clinicopathologic study[J].Transplantation,1997,64:252-257.
7Smith,D M;Agura,E;Netto,G,et al; Liver transplant-associated graft-versus-host disease[J].Transplantation,2003 Jan 15; 75(1):118-126.
8Billingham RE.The biology of graft-versus-host reactions[J].HarveyLeat,1996;62:21 78.
9Norris S,Doherty DG,Collins C,et al.Killer cell phenotype and function are hpenotypically heterogenous and include V[alpha]24-J[alpha]Q and[gamma][delta]T cell receptor bearing cells[J].Hum Immunol,1990;60:20-25.
10Lehner,F;Becker,T;Sybrecht,L,et al.Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosup-pression[J].Transplantation.2002 Jan 27;73(2):307-310.
